Pfizer Lands $2.15B Settlement From Teva, Sun Over Protonix

By Bill Donahue (June 12, 2013, 12:14 PM EDT) -- Pfizer Inc. said Wednesday that it has reached a $2.15 billion settlement with generic-drug makers Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. to resolve more than nine years of patent litigation over the acid-reflux drug Protonix....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!